tetano
Editor, Senior Moderator
J Surg Case Rep
. 2022 Feb 6;2022(2):rjac015.
doi: 10.1093/jscr/rjac015. eCollection 2022 Feb.
The impact of COVID-19 on delayed presentations of necrotising fasciitis
Quoc Dung Nguyen[SUP] 1 2 [/SUP], Jason Diab[SUP] 1 3 [/SUP], David Khaicy[SUP] 3 [/SUP], Vanessa Diab[SUP] 3 [/SUP], Zachias Hopkins[SUP] 3 [/SUP], Lai Heng Foong[SUP] 1 2 [/SUP], Christophe R Berney[SUP] 1 2 [/SUP]
Affiliations
Abstract
The purpose of this study was to determine the impact of coronavirus disease 2019 (COVID-19) on the delayed presentation of necrotising fasciitis (NF). A retrospective study was conducted of adult patients (≥16 years old) diagnosed with NF at a hospital from 2017 to 2020. A quantitative comparative analysis for the COVID-19 group and control group between 2017 and 2019. Structured interviews were conducted to examine the impact of COVID-19 on patients. There were 6 patients in the COVID-19 group and 10 patients in the control group. The COVID-19 group had a longer mean onset of symptoms till hospital presentation of 4.1 days and a longer mean operative time. The COVID-19 group was more likely to be admitted to intensive care unit. Three patients in the COVID-19 group did not survive compared to survival in the counterparts. Participant responses indicated the COVID-19 pandemic did not prevent them from presenting to ED.
. 2022 Feb 6;2022(2):rjac015.
doi: 10.1093/jscr/rjac015. eCollection 2022 Feb.
The impact of COVID-19 on delayed presentations of necrotising fasciitis
Quoc Dung Nguyen[SUP] 1 2 [/SUP], Jason Diab[SUP] 1 3 [/SUP], David Khaicy[SUP] 3 [/SUP], Vanessa Diab[SUP] 3 [/SUP], Zachias Hopkins[SUP] 3 [/SUP], Lai Heng Foong[SUP] 1 2 [/SUP], Christophe R Berney[SUP] 1 2 [/SUP]
Affiliations
- PMID: 35145627
- PMCID: PMC8826021
- DOI: 10.1093/jscr/rjac015
Abstract
The purpose of this study was to determine the impact of coronavirus disease 2019 (COVID-19) on the delayed presentation of necrotising fasciitis (NF). A retrospective study was conducted of adult patients (≥16 years old) diagnosed with NF at a hospital from 2017 to 2020. A quantitative comparative analysis for the COVID-19 group and control group between 2017 and 2019. Structured interviews were conducted to examine the impact of COVID-19 on patients. There were 6 patients in the COVID-19 group and 10 patients in the control group. The COVID-19 group had a longer mean onset of symptoms till hospital presentation of 4.1 days and a longer mean operative time. The COVID-19 group was more likely to be admitted to intensive care unit. Three patients in the COVID-19 group did not survive compared to survival in the counterparts. Participant responses indicated the COVID-19 pandemic did not prevent them from presenting to ED.